Analyst Ratings for Larimar Therapeutics (LRMR)
LRMR Rating Summary
LRMR Price Target Summary
- Highest: $25.00 (JMP Securities)
- Lowest: $10.00 (Citi)
- Average: $21.25
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$21.25 (+228.9%)
* Over Last 12-Mos
Rating Score: 8.3 / 10
Percentile Rank: 86%
Avg. $ Target:
$21.25 (+228.9%)
* Over Last 12-Mos
Rating Score: 8.3 / 10
Percentile Rank: 86%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/3/2024 | Leerink Partners | Joori Park | New Coverage | Outperform (N/A) |
25.00 (N/A) |
7.36 (6.46) |
-12.23% | Details |
| 11/17/2023 | Citi » Updated 2/13/2024 |
Samantha Semenkow | Upgrade | Buy (Neutral) |
10.00 (4.50) |
2.93 (6.46) |
120.48% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
